What Peptides Should I Take? A Physician-Guided Peptide Therapy Protocol

What peptides should I take? The answer comes from your goal, your health history, your current medications, your baseline labs, and whether a given peptide can be legally and safely prescribed or compounded today. A symptom checklist cannot supply those inputs. A physician reading your labs can, and that review turns a list of peptide names into a protocol built around what your body needs.

Most online advice treats peptide selection as a matching exercise: fat loss in, one peptide name out; recovery in, another name out. In clinical care the answer is filtered twice. First by your labs, history, and medications. Then by the regulatory status of the compound. For someone about to inject something, both filters are the whole decision, which is why peptide therapy works best as a physician-guided, lab-driven plan.

Key Takeaways

• The right peptide depends on your goal, health history, medications, baseline labs, and risk profile.
• Peptides are used for body composition, recovery, sleep, skin health, hormone support, and healthy aging. Each one fits some patients and not others.
• Legal and compounding status changes which options are available, so a protocol should be guided by a physician who follows both the clinical science and the current FDA position.

What Peptides Are and How They Work

Peptides are short chains of amino acids, the same building blocks that make up proteins. They are smaller than full proteins and usually larger and more targeted than traditional small-molecule drugs. Many peptides act as signals that tell a specific receptor to start or stop a process.¹

Different peptides bind to different receptors. Depending on the compound, that signal can influence appetite, hormone release, tissue repair, inflammation, skin function, sleep, or metabolism. Some peptides are made naturally by the body. Others are FDA-approved prescription medications, compounded therapies, or research compounds sold online without clinical oversight.¹

"Peptide therapy" is a broad category of compounds with different mechanisms, evidence levels, risks, and legal status. A peptide that supports growth hormone signaling works differently from one used for metabolic health or skin repair. Knowing which category a compound belongs to is the first step toward choosing well.

Three Clinical Inputs Behind Peptide Selection

Peptide selection starts with a clinical question: what are we trying to change, and why is that system not responding the way it should? Three inputs answer it.

1. Your goal. Some patients focus on body composition, appetite regulation, and metabolic health. Others want support for recovery, lean muscle, sleep quality, skin health, injury repair, or healthy aging.
2. Your medical history and medications. A peptide that suits one person may be inappropriate for someone with uncontrolled metabolic disease, a cancer concern, a hormone-sensitive history, autoimmune disease, pregnancy considerations, or certain cardiovascular risks. A patient already on a GLP-1 medication, testosterone therapy, thyroid medication, blood pressure medication, or an immune-modulating therapy needs a closer review than someone starting from scratch.
3. Your baseline labs. Depending on the goal, labs may include a hormone panel, metabolic and inflammatory markers, thyroid testing, lipids, liver and kidney function, blood counts, glucose and insulin markers, and nutrient status. Our biomarker guide explains what each group of markers measures.

Once those inputs are clear, a physician narrows the options. Sometimes one peptide fits. Sometimes a stack is reasonable. Sometimes the best first step is a different treatment altogether. The aim is a protocol that matches the patient, the data, and the risk-benefit profile.

Which Peptides Do What, Goal by Goal

Sorting peptides by clinical goal is the simplest way to see the options. Treat this chart as a starting map for a conversation with your physician, who confirms whether the goal is medically appropriate and whether the peptide can be legally and safely prescribed or compounded.

Goal	Peptides patients ask about	What they may do	What a physician evaluates
Weight loss and metabolic health	Semaglutide, tirzepatide, liraglutide	GLP-1 or incretin-based medications that can support appetite regulation, glucose control, and weight loss in appropriate patients.2	Weight history, BMI, A1c, fasting glucose, insulin resistance, kidney and liver markers, GI history, gallbladder or pancreatitis history, current medications, and whether an FDA-approved option is available. The FDA has stated that compounded copies of semaglutide and tirzepatide are not FDA-approved.3
Growth hormone signaling, recovery, sleep, body composition	Sermorelin; CJC-12954 and ipamorelin5 in online discussions	Discussed for their effect on growth hormone signaling. Sermorelin stimulates the body's own growth hormone release pathway instead of replacing growth hormone directly.6	IGF-1, fasting glucose, A1c, thyroid markers, sleep quality, sleep apnea risk, cancer history, edema risk, and cardiometabolic status. Geref, a sermorelin acetate product, was FDA-approved and later discontinued for reasons other than safety or effectiveness.7 The FDA has identified safety concerns for certain compounded uses of CJC-1295 and ipamorelin.8
Skin quality, hair support, cosmetic aging	GHK-Cu, especially topical copper peptide products9	Discussed for skin appearance, collagen support, wound-healing pathways, and cosmetic aging. Topical and injectable use are separate categories.	Skin goals, wound-healing history, copper status when relevant, sensitivity reactions, product quality, and route. The FDA has flagged injectable GHK-Cu for limited human safety data and potential immunogenicity.8
Injury recovery and tissue repair	BPC-157,10 TB-50011	Among the most searched peptides for tendon, ligament, gut, and soft-tissue recovery. Much of the support comes from animal, mechanistic, or anecdotal evidence rather than large human trials.	Injury type, imaging, diagnosis, medications, autoimmune status, clotting risk, cancer history, and any product sourced outside a regulated pharmacy. The FDA has cited limited safety information for BPC-157 and TB-500 in the compounding context.8
Inflammation and immune signaling	KPV,12 thymosin alpha-113	Discussed for immune modulation, inflammation, gut health, and recovery. Popular use has moved faster than high-quality clinical evidence for many wellness applications.	Autoimmune history, infection history, inflammatory markers, medication interactions, immune-modulating therapies, and source quality. The FDA lists safety and data limitations for both.8
Healthy aging and mitochondrial function	MOTS-c,14 epitalon15	Marketed online for longevity, metabolism, and mitochondrial function. The human evidence base for many of these claims is limited.	Metabolic labs, cardiovascular risk, sleep, training load, medications, goals, and whether a better-studied intervention should come first. In July 2026 an FDA advisory panel voted in favor of allowing compounding of both MOTS-c and epitalon; that vote is a recommendation, not final FDA action.16,17
Sexual health	Bremelanotide (PT-141)18	A melanocortin receptor agonist with a specific prescription indication.	Sex hormones, cardiovascular risk, blood pressure, medication effects, relationship and mental health factors, and fit with the approved indication. Vyleesi is FDA-approved for premenopausal women with acquired, generalized hypoactive sexual desire disorder.19
Abdominal fat in a narrow medical context	Tesamorelin20	Discussed online for body composition, though its FDA-approved use is much narrower than general fat loss.	HIV history, lipodystrophy diagnosis, glucose control, IGF-1, cancer history, and cardiometabolic risk. Egrifta SV is indicated for excess abdominal fat in adults with HIV-associated lipodystrophy.20

A peptide name becomes useful only after the clinical context is clear. The working questions are which system we are trying to influence, what the labs show, which risks need to be ruled out, and whether there is a legal, high-quality, physician-supervised way to use the compound. For deeper reading on individual peptides, see our guides to sermorelin, sermorelin vs. ipamorelin, HGH peptides, GHK-Cu, PT-141, and semaglutide vs. tirzepatide.

Answering “What Peptides Should I Take?” in Five Steps

A peptide protocol is built in order. The goal is to identify what your body needs, choose an appropriate option, and monitor whether it is working safely.

1. Define your goal and health history.
2. Get baseline labs.
3. Match peptide options to your labs and goal with a physician.
4. Start conservatively and monitor.
5. Reassess and adjust the stack.

Step 1: Define Your Goal and Health History

Start by naming the primary goal: weight loss, metabolic health, recovery, lean muscle, sleep quality, skin health, sexual health, or healthy aging. The physician then adds context. Current medications, medical conditions, hormone history, cancer history, cardiovascular risk, autoimmune disease, pregnancy considerations, and prior treatment response all shape whether a peptide is appropriate.

Step 2: Get Baseline Labs

Baseline labs turn peptide selection into a clinical decision. They also show when a peptide is not the best first move. Sometimes the underlying issue is untreated low testosterone, insulin resistance, poor sleep, thyroid dysfunction, inflammation, or nutrient depletion. A testosterone blood test is often part of that first panel for men.

Step 3: Match What Peptides You Take to Your Labs and Goal

With goal, history, medications, and labs in hand, a physician narrows the list to a specific recommendation. That may be one peptide, a carefully chosen stack, or a different therapy entirely. The same peptide carries different implications depending on glucose control, hormone status, cancer history, blood pressure, immune activity, and other treatments you already use.

Step 4: Start Conservatively and Monitor

A good protocol begins with the lowest effective strategy and a defined check-in point. Monitoring covers symptoms, side effects, progress toward the original goal, and relevant lab changes. When one intervention is working, that result is the reason to hold off on adding another.

Step 5: Reassess and Adjust the Stack

Peptide therapy changes over time. The protocol is reassessed on response, side effects, updated labs, and whether each peptide remains appropriate under current regulations. The review question is what is still needed, what is working, and what should be adjusted or removed.

What Peptide Stacking Means

Peptide stacking is combining two or more peptides with complementary mechanisms in the same treatment protocol. Different peptides may support different pathways, such as metabolic health, recovery, sleep, skin quality, or hormone signaling. In a physician-guided setting, each peptide in a stack has a stated reason for being there.

A clinician might consider one peptide for appetite regulation and another for recovery or body composition. Before combining them, the physician reviews your labs, medications, medical history, side-effect risk, and treatment priorities. A stack is built around a clinical rationale and your own data.

Self-stacking research-chemical vials bought outside a regulated medical setting adds risk in two ways: the individual risk of each compound, and the unknown risk of combining them with no one monitoring. A supervised stack replaces both with a plan and a follow-up schedule.

Prescription, Compounded, and Gray-Market Peptides Compared

Peptides discussed online fall into three categories with very different safeguards.

Criteria	FDA-approved prescription	Physician-supervised compounded	Gray-market “research” peptide
FDA review before reaching patients	Yes, for a specific indication, dose, route, and population	No. Compounded drugs are not FDA-approved21	No
Pharmacy standards	FDA-regulated manufacturing	503A pharmacies and 503B outsourcing facilities must meet federal conditions21,22	None verified; often labeled “not for human use”
Physician oversight	Prescription required	Prescription required	Usually none
Examples	Certain GLP-1 medications, tesamorelin (Egrifta SV), bremelanotide (Vyleesi)	Used when an FDA-approved product is not appropriate for a specific patient	Many trending peptides sold online
Verdict	First choice when an approved product fits your indication	Reasonable when legally appropriate and prescribed after lab review	Highest risk; avoid for self-injection

Prescription peptides have gone through the FDA approval process for a specific indication. Examples include certain GLP-1 medications for diabetes or weight management, tesamorelin for HIV-associated lipodystrophy, and bremelanotide for a specific sexual health indication. These drugs still require medical judgment, but their safety, effectiveness, labeling, and manufacturing were reviewed through a formal pathway.

Physician-supervised compounded peptides can have a role when an FDA-approved product does not suit a specific patient. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before reaching patients. Federal law sets conditions for 503A pharmacies and 503B outsourcing facilities, including rules on bulk drug substances and on products that are too similar to an available FDA-approved drug.^21,22 Our compounded semaglutide guide walks through how this plays out for one widely used medication.

Gray-market peptides are sold online as “research chemicals” even when buyers clearly intend to self-inject. The concerns include identity, purity, sterility, dose accuracy, contamination, storage conditions, and the absence of a clinician watching for side effects or interactions. Choosing between the first two categories with a physician is the practical way to stay out of the third.

Choosing a Regulated Peptide Source

The gray market is the space where peptides are sold outside the normal medical and pharmacy system, often labeled “for laboratory use” or “not for human use.” Buying there is different from receiving an FDA-approved prescription, and different from working with a physician and a regulated pharmacy when compounding is legally appropriate.

Whether a peptide works is only part of the question. You also need to know whether the vial holds what the label says, whether the dose is accurate, whether the product is sterile and stored correctly, and whether contaminants or peptide-related impurities are present. With an injectable product, each of those is a safety issue.

Legitimate compounding has limits too. The FDA states that compounded drugs are not FDA-approved and warns that poor compounding practices can lead to contamination or products without the strength, quality, or purity they are supposed to have.²¹ Gray-market products may come without a real prescription, a verified pharmacy, sterile handling, adverse-event monitoring, or a clinician checking the peptide against your labs and history.

Many trending peptides also have the thinnest clinical footing. The FDA has identified safety concerns or limited safety information for BPC-157, CJC-1295, injectable GHK-Cu, KPV, MOTS-c, thymosin alpha-1, and TB-500 in the compounding context.⁸ A physician-guided protocol replaces “What are people using online?” with five better questions:

• Is this product legally appropriate?
• Is there a safer FDA-approved option?
• Do my labs support it?
• Is the source a regulated pharmacy?
• Who is monitoring me if something changes?

If cost is part of your decision, our peptide therapy cost guide breaks down what a supervised program includes.

Sermorelin and HGH Compared

Sermorelin and HGH are often discussed together, but they work differently. Sermorelin is a growth hormone–releasing hormone analog that signals the pituitary gland to release growth hormone.⁶ HGH, or somatropin, is recombinant human growth hormone itself.

Sermorelin works through the body's own signaling pathway, while HGH replaces growth hormone directly and is FDA-approved for specific pediatric and adult growth hormone deficiency indications. HGH is not approved as a general anti-aging medication. Geref, a sermorelin acetate product, was discontinued but not withdrawn for safety or effectiveness reasons.⁷ Growth hormone support is guided by symptoms, labs, risk factors, and physician review. Our human growth hormone guide covers HGH in more detail.

From Picking a Peptide to a Physician-Guided Protocol

A goal-based peptide guide organizes the conversation. It shows why certain peptides come up for weight loss, recovery, sleep, skin, muscle, or healthy aging. The better question to bring to that conversation is what your body needs and the safest way to address it.

A patient asking about recovery may need hormone, inflammatory, or sleep-related markers reviewed. A patient interested in skin or aging support may need the basics checked before adding anything injectable. With that context, the physician decides whether a peptide is appropriate, whether another treatment should come first, whether a stack is reasonable, and what to monitor over time. Women have their own considerations, covered in our peptide therapy for women overview.

The best peptide protocol is medically appropriate, legally appropriate, lab-informed, and adjusted as your body responds.

The Opt Take on What Peptides to Take

So, what peptides should I take? At Opt Health, we answer that question with measurement first. Every member starts with a panel of 55 or more biomarkers and a one-on-one consultation with an Opt Health physician. Existing conditions and current medications are reviewed before any plan is built, and a physician reads every lab before anyone is offered a treatment.

When peptides belong in your plan, they are prescribed and shipped from our pharmacy to your door. Labs and a physician consultation repeat every three to four months, so the protocol changes based on what your numbers did. You can see the full process on the How Opt Health Works page.

Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.

Frequently Asked Questions

This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.